25 years after the `Rio Convention'––Lessons learned in the context of sustainable development and protecting indigenous and local knowledge

Phytomedicine

Volumn 53, Issue , 2019, Pages 332-343

  Heinrich, Michael ^a   Hesketh, Alan ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b Indigena Biodiversity Ltd   (United Kingdom)

Author keywords

Convention on biological diversity; Ethnopharmacology; Intellectual property; Lepidium meyenii Walp. (maca); Nagoya protocol; Traditional medicine

Indexed keywords

LEPIDIUM MEYENII EXTRACT; NATURAL PRODUCT; PHYTOCHEMICAL; QUININE; RUBBER; BIOLOGICAL PRODUCT;

BIODIVERSITY; BIOPROSPECTING; COMMUNITY; GENETIC RESOURCE; HUMAN; INDIGENOUS PEOPLE; INVESTMENT; KNOWLEDGE; ORGANIZATION AND MANAGEMENT; PATENT; PRIORITY JOURNAL; RECOGNITION; RESPECT; REVIEW; SPECIES; SUSTAINABLE DEVELOPMENT; CHEMISTRY; EUPHORBIA; INTERNATIONAL COOPERATION; LEPIDIUM; MEDICINAL PLANT;

BIODIVERSITY; BIOLOGICAL PRODUCTS; EUPHORBIA; HUMANS; INTELLECTUAL PROPERTY; INTERNATIONAL COOPERATION; LEPIDIUM; OWNERSHIP; PATENTS AS TOPIC; PLANTS, MEDICINAL; SUSTAINABLE DEVELOPMENT;

EID: 85054594652     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2018.04.061     Document Type: Review

References (24)

1. Beharry, S., Heinrich, M., Is the hype around the reproductive health claims of maca (Lepidium meyenii Walp) justified?. J. Ethnopharmacol. 211 (2018), 126–170.
2. Berlin, B., Berlin, E.A., Ugalde, J.C.F., Barrios, L.G., Puett, D., Nash, R., Gonzalez-Espinoza, M., The Maya ICBG: drug discovery, medical ethnobiology, and alternative forms of economic development in the Highland Maya region of Chiapas. Mexico. Pharm. Biol. 37 (1999), 127–144.
3. Biber-Klemm, S., Martinez, S.I., Utilization of genetic resources and associated traditional knowledge in academic research. A good practice guide for access and benefit-sharing. 3rd ed. Swiss Academy of Sciences (SCNAT), 2016 Bern, Switzerland.
4. Bullard, L., NW resistance against genetic engineering, A briefing paper on the neem biopiracy case, NW Resistance Against Genetic Engineering (NWRAGE) available at., 2005 http://nwrage.org/content/freeing-free-tree-briefing-paper-neem-biopiracy-case (accessed 6 Dec 2017).
5. Comas, M., Miquel, X., Arias, G., de la Torre, M.C., Estudio bromatologico de la maca o paca. Alimentaria 286 (1997), 85–90.
6. Delegation of Peru. IGC 5th Session, Patents referring to Lepidium meyenii (maca): responses of Peru, Document submitted by the Delegation of Peru. Available at., 2003 http://www.wipo.int/edocs/mdocs/tk/en/wipo_grtkf_ic_5/wipo_grtkf_ic_5_13.pdf (accessed 3 Dec 2017).
7. Dini. Chemical composition of Lepidium meyenii. Food Chem. 49 (1994), 346–347.
8. E.U. (European Union) n.d. Sharing nature's genetic resources – ABS. http://ec.europa.eu/environment/nature/biodiversity/international/abs/index_en.htm (last accessed 29.12.17).
9. Gramiccia, G., The Life of Charles Ledger, (1818 - 1905): Alpacas and Quinine. 1988, Basingstoke, Macmillan.
10. Heinrich, M., Ethnopharmacology and drug development. Reedijk, J., (eds.) Elsevier Reference Module in Chemistry, Molecular Sciences and Chemical Engineering, 2013, Elsevier, Waltham, MA, 10.1016/B978-0-12-409547-2.02773-6 11-Sep-13.
11. Heinrich, M., Jaeger, A.K., New medicines based on traditional knowledge: indigenous and intellectual property rights from an ethnopharmacological perspective. Ethnopharmacology, 2015, Wiley, Chichester, UK.
12. Heinrich, M., Leonti, M., Frei Haller, B., A perspective on natural products research and ethnopharmacology in México. The eagle and the serpent on the prickly pear cactus. J.Nat. Prod. 77 (2014), 678–689.
13. Heinrich, M., Lardos, A., Leonti, M., Weckerle, C., Willcox, M., with the ConSEFS advisory group. Best Practice in Research: Consensus Statement on Ethnopharmacological Field Studies – ConSEFS. J. Ethnopharmacol. 211 (2018), 329–339, 10.1016/j.jep.2017.08.015.
14. Hesketh, A., Ethnopharmacoloy and Intellectual Property Rights. Heinrich, M., Jaeger, A.K., (eds.) 2015. Ethnopharmacology, 2015, Wiley, Chichester, UK, 87–96 Chapter 9.
15. LePestre, P., The CBD at Ten: the long Road to Effectiveness. J. Int. Wildlife Law Policy 5 (2002), 269–285.
16. Ponting, C., A New Green History of the World: The Environment and the Collapse of Great Civilizations. 2007, Penguin Books, New York.
17. Posey, D.A., Dutfield, G., Beyond Intellectual Property: Traditional Resource Rights for Indigenous Peoples and Local Communities. 1996, International Development Research Centre, Ottawa, Canada.
18. Posey, D.A., edited by Kristina Plenderleith. Indigenous Knowledge and Ethics. A Darrell Posey Reader. 2004, Routledge, New York and London.
19. Rowland, DL., Tai, W., A review of plant-derived and herbal approaches to the treatment of sexual dysfunctions. J. Sex Marital Ther. 29 (2003), 185–205.
20. Rosenthal, J.P, n.d. The International Cooperative Biodiversity Groups (ICBG) program. www.cbd.int/doc/case-studies/abs/cs-abs-icbg.pdf (ca. 1999; last accessed 29/12/2017).
21. Schultes, R.E., Raffauf, R.F., The Healing Forest: Medicinal and Toxic Plants of the Northwest. 1990, Amazonia. Dioscorides Press, Portland, Oregon.
22. Singh, R.D., Mody, S.K., Patel, H.B., Devi, S., Modi, C.M., Kamani, D.R., A review on Pharmaceutical biopiracy and protection of traditional knowledge. Int. J. Res. Dev. Pharm. L. Sci. 2014:3 (2014), 866–871.
23. Tu., YY., Artemisinin - a gift from traditional chinese medicine to the world (nobel lecture). Angew. Chem. Int. Ed., 35, 2016, 10210.
24. Wells, W.A., Rainforest remedies Shaman pharmaceuticals. Inc. Chem. Biol. 5 (1998), R63–R64.